The universities and their leadership and some faculty will forever own their active and passive tolerance and sometimes support for acts of hate that occur on campus, tarnishing the reputations of our academic institutions and mocking assertions that demonstrators are peaceful

Towards improved clinical utility for prediction of hip #fracture Nature Aging nature.com/articles/s4358…

More heterogeneity of gestational #diabetes Diabetologia link.springer.com/article/10.100…

As noted in SELECT the renal benefits of Semaglutide extend to PPL with #obesity Nature Medicine nature.com/articles/s4159… #kidney disease

Congratulations to Juleen Zierath who is the recipient of the EASD-Novo Nordisk Foundation Diabetes Prize for Excellence 2024! 👏
Juleen R. Zierath receives the award at #EASD2024 in Madrid to recognise her outstanding achievements in #diabetes #research .
Novo Nordisk Foundation

Make no mistake, there is a concerted international campaign to do away with the world’s only, tiny Jewish country. Israel is currently fighting for its life, surrounded on all sides by an ideologically singular enemy whose only goal is to destroy it.

The strategy of a small

Assessment of tissue glucocorticoid status-where do we stand #EndocrineReviews academic.oup.com/edrv/advance-a…

GLP-1 acts on multiple discrete sparse receptors and engages central and peripheral neuronal GLP-1R+ circuits to modify organ function and reduce inflammation. None of these contributing actions can be measured via a mediation analysis

Tragically brilliant Navigating The American Healthcare System | South Park: The End Of #Obesity youtu.be/VAfy26xs6e0?si… via YouTube

Support for MS152 as a first-in-class EHMT2/G9a inhibitor to advance the epigenetic therapy of #PraderWillisyndrome #PWS in humans #obesity cell.com/molecular-ther…

A brain-derived #insulin signal encodes protein satiety and suppresses feeding behavior in a nutrient-specific manner in Drosophila Cell Reports cell.com/cell-reports/f…

I’ll be speaking on common #GLP1 side effects and how to manage them in your patients!

There’s still time to register for #ADA2024 American Diabetes Association 👉 professional.diabetes.org/scientific-ses…

Outstanding news about #semaglutide #PreventingDeath and #KidneyFailure .
Says nephrologist Katherine Tuttle:
“Those of us who really care about kidney patients spent our whole careers wanting something better. And this is as good as it gets.”
conscienhealth.org/2024/05/semagl…

Among the symposia this year #ADA2024 ⁦American Diabetes Association⁩ in Orlando, June 23, the safety of GLP-1 medicines for #obesity What have we learned, where do the uncertainties linger ⁦Beverly G. Tchang, MD⁩

It is not likely all future semaglutide trials will be positive-which one(s) may disappoint?

The popular press loves to worry about the side effects of semaglutide, a member of a drug class used for 19 years in millions of PPL, that reduces heart attacks, strokes, cardiovascular death, kidney disease, and all cause mortality #CVD #T2D #obesity apple.news/AZm_yCcWjTte0V…

A role for T cells in regulation of intestinal motility and the cytokines IL-1β and IL-17A in enteric neurogenesis biorxiv.org/content/10.110…

The human gut bacteria Gordonibacter pamelaeae and Eggerthella lenta convert biliary corticoids into progestins through 21-dehydroxylation, transforming immuno- and metabo-regulatory steroids into a class of sex hormones and neurosteroids Cell cell.com/cell/abstract/…

MXRA8 promotes whitening of beige and brown adipose tissues to drive #obesity pathogenesis identifying MXRA8 as a possible therapeutic target to treat #obesity and associated metabolic diseases. biorxiv.org/content/10.110…